论文部分内容阅读
本刊讯国家食品药品监督管理局等5部委 (局 )2003年4月24日发布紧急通知指出 ,用于防治“非典”的方剂处方必须经卫生部防治非典型肺炎领导小组审定同意后方可发布。这一通知无疑是针对当前社会上流传的多种号称自已可以防治非典的方剂处方而出台的。5部委 (局 )发布的紧急通知
According to the urgent notice issued on April 24, 2003, the SFDA and other five ministries and commissions (State Bureau of Food and Drug Administration) pointed out that prescriptions for prescription of SARS prevention and control must be approved by the Leading Group for SARS Prevention and Control issued by the Ministry of Public Health before release . This notice is undoubtedly aiming at the various kinds of prescriptions prevalent in the society that claim to prevent SARS. 5 ministries (bureau) issued an emergency notice